CASP3 and breast cancer: In conclusion, this study suggests that BC elicits anti-apoptotic activity in AsPC-1 in-vitro by increasing cell viability, decreasing caspase 3 activity, stabilising the ∆Ψm, and scavenging free radicals (see graphical abstract in Fig. 8).